Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 2,361

The crypto scene continues to remain so hot that bitcoin is hitting one new high after another. It surpassed $72,700 on Monday. This was initially driven by the approval of spot bitcoin ETFs, but is now being pushed higher ahead of a “halving” event, which will limit the amount of new supply put into circulation from bitcoin miners.

Bitcoin has increased 9.5% in the past seven days and is up 50% on the month, according to CoinMarketCap data. The total crypto market cap across all tokens has increased 10% on the week to $2.71 trillion, with bitcoin making up 52.7% of that amount.

There is, of course, no way of telling how high bitcoin can rise during the current bull frenzy. While many are feeling the hopium, there’s at least one indicator that thinks we’re nearing the top of the highs, with price dips to quickly follow.

Read more | >

From the article:

“Somewhere between one and ten million qubits are needed for a fault-tolerant quantum computer, whereas IBM has only just realized a 1,200-qubit computer,” says Aoki.

While this approach isn’t limited to any specific platform for quantum computers, it does lend itself to trapped ions and neutral atoms since they don’t need to be cooled to cryogenic temperatures, which makes them much easier to connect.

A hybrid approach

Aoki and his team are investigating the possibility of using a hybrid quantum system of atoms and photons known as a cavity quantum electrodynamics (QED) system as a promising way to connect units. “Cavity QED provides an ideal interface between optical qubits and atomic qubits for distributed quantum computing,” says Aoki. “Recently, key building blocks for realizing quantum computers based on cavity QED, such as single-photon sources and various quantum gates, have been demonstrated using free-space cavities.”

Read more | >

People in the daratumumab group who stayed MRD negative for at least a year were able to stop taking daratumumab as maintenance therapy and remained cancer free. That’s important, Dr. Sonneveld said, because taking fewer drugs long-term for maintenance therapy often translates to a better well-being and quality of life.

Adding daratumumab to the standard treatment resulted in a nearly 60% drop in the risk of cancer progression or death (hazard ratio of 0.42), the researchers determined.

The magnitude of that change is “unprecedented in these kinds of phase 3 trials [for] multiple myeloma,” Dr. Sonneveld said.

Read more | >